Testing effectiveness (Phase 2)UnknownNCT04782128What this trial is testingEvaluation of RC28-E Injection in Diabetic RetinopathyWho this might be right forDiabetic Retinopathy RemeGen Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00198471What this trial is testingAssessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous DetachmentWho this might be right forVitreous DetachmentDiabetic Retinopathy Bausch & Lomb Incorporated 10
Large-scale testing (Phase 3)Study completedNCT00131144What this trial is testingOctreotide Acetate in Microspheres in Patients With Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Novartis 583
Post-approval studies (Phase 4)UnknownNCT04283162What this trial is testingUsing Calcium Dobesilate to Treat Chinese Patients With Mild to Moderate Non-proliferative Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Zhongda Hospital 1,200
Testing effectiveness (Phase 2)Study completedNCT04692688What this trial is testingStudy of the Safety and Efficacy of APX3330 in Diabetic RetinopathyWho this might be right forDiabetic RetinopathyDiabetic Macular EdemaNPDR - Non Proliferative Diabetic Retinopathy+1 more Ocuphire Pharma, Inc. 103
Large-scale testing (Phase 3)Enrolling By InvitationNCT06951087What this trial is testingIntravitreal and Intracameral DEX in NPDRWho this might be right forNon-Proliferative Diabetic Retinopathy Affiliated Hospital of Nantong University 80
Large-scale testing (Phase 3)Ended earlyNCT05066230What this trial is testingEvaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)Who this might be right forNon-proliferative Diabetic Retinopathy Kodiak Sciences Inc 253
Testing effectiveness (Phase 2)Study completedNCT05383209What this trial is testingStudy of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)Who this might be right forNonproliferative Diabetic Retinopathy EyePoint Pharmaceuticals, Inc. 77
Testing effectiveness (Phase 2)Study completedNCT00917553What this trial is testingEvaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Thomas Gardner 33
Testing effectiveness (Phase 2)Study completedNCT00511875What this trial is testingEvaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Thomas Gardner 30
Post-approval studies (Phase 4)WithdrawnNCT04702048What this trial is testingEvaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the EyeWho this might be right forRetinopathy, Diabetic University of Rochester
Large-scale testing (Phase 3)Ended earlyNCT00248157What this trial is testingExtension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Novartis Pharmaceuticals 105
Not applicableStudy completedNCT05543564What this trial is testingProphylactic PRP in Moderate NPDRWho this might be right forEye DiseasesDiabetesDiabetic Retinopathy Assiut University 68
Large-scale testing (Phase 3)Ended earlyNCT00248131What this trial is testingExtension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Novartis Pharmaceuticals 260
Testing effectiveness (Phase 2)Study completedNCT01295775What this trial is testingDiabetic Retinopathy Sulodexide StudyWho this might be right forDiabetic Retinopathy Ajou University School of Medicine 127
Not applicableStudy completedNCT03696810What this trial is testingCharacterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2Who this might be right forNPDR - Non Proliferative Diabetic Retinopathy Association for Innovation and Biomedical Research on Light and Image 141
Testing effectiveness (Phase 2)Study completedNCT04722991What this trial is testingNon-proliferative Diabetic Retinopathy Treated With RuncaciguatWho this might be right forDiabetic Retinopathy Bayer 109
Early research (Phase 1)UnknownNCT05695417What this trial is testingStudy to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic RetinopathyWho this might be right forNon-proliferative Diabetic Retinopathy Ocular Therapeutix, Inc. 21
Large-scale testing (Phase 3)Study completedNCT00130845What this trial is testingOctreotide Acetate in Microspheres in Patients With Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Novartis 312
Testing effectiveness (Phase 2)Study completedNCT03197870What this trial is testingThe TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)Who this might be right forNonproliferative Diabetic Retinopathy EyePoint Pharmaceuticals, Inc. 167